European Journal of Cancer and Clinical Oncology
Specialist interest articleNeural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
References (20)
- et al.
Results of the central data analysis
Lung Cancer
(1988) - et al.
Monoclonal antibody 123c3 in lung tumour classification: immunohistology of 358 resected lung tumours
Mol Cell Probes
(1988) Staging in lung cancer, UICC 1987
Chest
(1986)The World Health Organization Histological Typing of Lung Tumours
(1981)- et al.
Expression of an N-CAM related sialoglycoprotein in small cell lung cancer and neuroblastoma
Cancer Res
(1990) - et al.
Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumor cells
Immunol Res
(1987) - et al.
Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms' tumor
- et al.
Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1
Nature
(1984) - et al.
The L2/HNK-1 carbohydrate of neural cell adhesion molecules is involved in cell interactions
J Cell Biol
(1988) - et al.
Establishment of continuous, clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties
Cancer Res
(1985)
Cited by (83)
Pathology of Lung Cancer
2011, Clinics in Chest MedicineCitation Excerpt :Iyoda and colleagues139 found that the tumor size of large cell carcinoma with NED (LCC-ND) was larger than that for LCNEC (P = .0033), but the survival was not different from patients with LCNEC. Whether these tumors are responsive to SCLC chemotherapy regimens143,144 or whether expression of NE markers may be an unfavorable prognostic factor145–152 remains to be determined. Adenosquamous carcinoma accounts for 0.6% to 2.3% of all lung cancers153–157 and it is defined as a lung carcinoma having at least 10% squamous cell and adenocarcinoma by light microscopy.36
Endobronchial ultrasound for diagnosis of synchronous primary lung cancers
2009, Lung CancerCitation Excerpt :Immunostaining for p63 and TTF-1 has been shown to be useful in differentiating between SCLC and poorly differentiated SCC, with predominantly TTF-1 positivity in SCLC and p63 positivity in SCC [9]. Comparative studies have suggested CD56 as the most sensitive marker in the diagnosis of SCLC [10,11]. An alternative to EBUS for minimally invasive assessment of the mediastinal lymph nodes is by endoscopic ultrasound guided fine needle aspiration (EUS-FNA) via the transesophageal route.
Peripheral arterial ischemia by a primary lung tumour invading left atrium
2007, Lung CancerCitation Excerpt :Another notable feature of this report is that the histology on original CT guided biopsy showed it to be poorly differentiated non-small cell carcinoma with no CD 56 staining where as the histology of the embolus was that of small cell carcinoma intensely stained with CD 56. CD 56 has become the antibody of choice in diagnosis of small cell carcinoma because the sensitivities for other antibodies in small cell carcinoma vary [10,11,12] and comparative studies suggest that CD56 is the most sensitive marker in this context [13,14]. Kotogianni et al. [15] have suggested use of CD56, MND116 and TTF1 as a useful panel of immunohistochemical markers for diagnosis of small cell lung cancer (SCLC).
ProGRP: A new biomarker for small cell lung cancer
2004, Clinical BiochemistryMonoclonal antibodies to the exon 18 encoded moiety of NCAM
2019, Journal of Cancer Metastasis and Treatment